Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
2 structures for P18568
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 3WA1 | X-ray | 175 A | A | 19-407 | PDB |
| AF-P18568-F1 | Predicted | AlphaFoldDB |
No variants for P18568
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for P18568 | |||||
No associated diseases with P18568
1 regional properties for P18568
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Insecticidal crystal toxin | 235 - 396 | IPR008872 |
No GO annotations of cellular component
| Name | Definition |
|---|---|
| No GO annotations for cellular component |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| toxin activity | Interacting selectively with one or more biological molecules in another (target) organism, initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target organism. The activity should refer to an evolved function of the active gene product, i.e. one that was selected for. Examples include the activity of botulinum toxin, and snake venom. |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| sporulation resulting in formation of a cellular spore | The process in which a relatively unspecialized cell acquires the specialized features of a cellular spore, a cell form that can be used for dissemination, for survival of adverse conditions because of its heat and dessication resistance, and/or for reproduction. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MCDSKDNSGV | SEKCGKKFTN | YPLNTTPTSL | NYNLPEISKK | FYNLKNKYSR | NGYGLSKTEF |
| 70 | 80 | 90 | 100 | 110 | 120 |
| PSSIENCPSN | EYSIMYDNKD | PRFLIRFLLD | DGRYIIADRD | DGEVFDEAPT | YLDNNNHPII |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SRHYTGEERQ | KFEQVGSGDY | ITGEQFFQFY | TQNKTRVLSN | CRALDSRTIL | LSTAKIFPIY |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PPASETQLTA | FVNSSFYAAA | IPQLPQTSLL | ENIPEPTSLD | DSGVLPKDAV | RAVKGSALLP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| CIIVHDPNLN | NSDKMKFNTY | YLLEYKEYWH | QLWSQIIPAH | QTVKIQERTG | ISEVVQNSMI |
| 310 | 320 | 330 | 340 | 350 | 360 |
| EDLNMYIGAD | FGMYFYLRSS | GFKEQITRGL | NRPLSQTPTQ | LGERVEEMEY | YNSNDLDVRY |
| 370 | 380 | 390 | 400 | 410 | 420 |
| VKHALAREFT | LKRVNGEIVK | NWVAVDYRMA | GIQSYPNAPI | TNPLTLTKHT | IIRCENSYDG |
| 430 | 440 | ||||
| HIFKTPLIFK | NGEVIVKTNE | ELIPKINQ |